Kanoria Chemicals & Industries Ltd approves Q2/H1 FY27 results and Rajya Vardhan Kanoria’s three-year MD reappointment
- Approved unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026, along with limited review reports.
- Reappointment as Managing Director to run from 10 January 2027 to 9 January 2030, subject to shareholder approval.
